Amgen's fast-growing cancer immunotherapy Imdelltra could move into the first-line setting in small cell lung cancer (SCLC), ...

The pivotal QUINTESSENTIAL trial of the potentially first-in-class CAR-T showed a "statistically significant and clinically ...

The FDA has started a priority review of AstraZeneca's IL-33-targeting antibody tozorakimab for chronic obstructive pulmonary ...

An AI-powered imaging tool developed by Brainomix has been used to enrich data from a phase 2a trial of Endeavor BioMedicines ...

Registration and the full programme are available on the DIA-MHRA Global Summit page. Follow the conversation at ...

Every few years, drug development goes through a moment where a new technology promises to change everything. Artificial ...

Different regions have distinct healthcare systems, varying access levels, reimbursement models, and treatment realities — ...

As cell therapy for autoimmune disease transitions from breakthrough clinical case studies to broad clinical validation, developers are racing to overcome challenges around safety, scalability, ...

Uniting leaders pioneering complement-targeted therapies across ophthalmology, neurodegeneration, nephrology, oncology and ...

Speaking to investors and analysts at its capital markets day in London, UK, Sandoz presented its new strategy – Bio100 – ...

It's well-established that breathing exercises can improve symptoms in COPD by freeing stale air that remains trapped in the ...

Omnideployment is not about multiplying touchpoints or increasing the volume of communications. It is the precise ...